Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Boston MA, Philadelphia PA, Montreal, Toronto, Hamilton,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase3, Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Boston MA, New Haven CT, New York NY, Toronto,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase1, Phase2, Recruiting
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Cleveland OH,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07140900
Phase1, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, Worcester MA, Hackensack NJ, New York NY,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase2, Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 40+
Code: NCT07072039
Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Boston MA, Columbus OH, Milwaukee WI, Atlanta GA,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06707493
Phase2, Recruiting
Subcortical Arousal in Perceptual Awareness
for
Epilepsy
Location: Boston MA, New Haven CT, Lebanon NH, Nashville TN,
Sponsor: Yale University
Sex: All
Age: 13+
Code: NCT06934356
Recruiting
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
for
Acute Myeloid Leukemia
Location: Boston MA, New York NY, Baltimore MD, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12+
Code: NCT06284486
Phase1, Phase2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Boston MA, Hartford CT, Philadelphia PA, Rochester NY,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
for
Charcot Marie Tooth Disease
Location: Boston MA, Hartford CT, Philadelphia PA, Rochester NY,
Sponsor: Michael Shy
Sex: All
Age: 0+
Code: NCT01193075
Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Boston MA, Hartford CT, Charlottesville VA, Houston TX,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase1, Phase2, Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, DuBois PA, London,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Recruiting
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
for
Cancer Diagnosis
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 45+
Code: NCT06523868
Recruiting
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer